SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4z0b'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2KUH_A_HLTA150_1
(CALMODULIN)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
4 / 6 LEU H  79
LEU H   4
MET H  34
GLU H  35
None
1.26A 2kuhA-4z0bH:
undetectable
2kuhA-4z0bH:
12.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WLK_B_SPMB1302_1
(ATP-SENSITIVE INWARD
RECTIFIER POTASSIUM
CHANNEL 10)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
4 / 4 ALA H  49
TYR H  50
ALA H  61
TYR H  59
None
1.24A 2wlkA-4z0bH:
2.5
2wlkB-4z0bH:
2.1
2wlkA-4z0bH:
20.33
2wlkB-4z0bH:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUH_A_ACTA610_0
(SERUM ALBUMIN)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 VAL H 191
SER H 192
THR H 195
None
0.31A 4luhA-4z0bH:
undetectable
4luhA-4z0bH:
17.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MJ8_A_SPMA201_1
(SPERMIDINE
N1-ACETYLTRANSFERASE)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
4 / 8 MET H 109
GLU H  35
TYR H  95
TYR H  80
None
1.21A 4mj8A-4z0bH:
undetectable
4mj8C-4z0bH:
undetectable
4mj8A-4z0bH:
17.11
4mj8C-4z0bH:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O2B_B_LOCB503_1
(TUBULIN ALPHA-1B
CHAIN
TUBULIN BETA-2B
CHAIN)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 SER H 211
ALA H 206
VAL H 205
None
0.62A 4o2bA-4z0bH:
undetectable
4o2bA-4z0bH:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EYP_B_LOCB502_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 SER H 211
ALA H 206
VAL H 205
None
0.56A 5eypA-4z0bH:
undetectable
5eypA-4z0bH:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HSW_A_ACTA501_0
(ORF 37)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
4 / 5 SER H 192
SER H 193
SER H 194
SER H 142
None
0.88A 5hswA-4z0bH:
undetectable
5hswA-4z0bH:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JLC_A_1YNA602_2
(LANOSTEROL 14-ALPHA
DEMETHYLASE)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
4 / 5 TYR H  95
GLY H 115
THR H 116
GLY H 170
None
0.92A 5jlcA-4z0bH:
undetectable
5jlcA-4z0bH:
18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_A_1GNA607_1
(PHIAB6 TAILSPIKE)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 THR H  28
SER H  31
TYR H  32
None
0.71A 5jsdA-4z0bH:
undetectable
5jsdA-4z0bH:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_B_1GNB618_1
(PHIAB6 TAILSPIKE)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 THR H  28
SER H  31
TYR H  32
None
0.72A 5jsdB-4z0bH:
undetectable
5jsdB-4z0bH:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_C_1GNC608_1
(PHIAB6 TAILSPIKE)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 THR H  28
SER H  31
TYR H  32
None
0.71A 5jsdC-4z0bH:
undetectable
5jsdC-4z0bH:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_A_1GNA608_1
(PHIAB6 TAILSPIKE)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 THR H  28
SER H  31
TYR H  32
None
0.74A 5jseA-4z0bH:
2.4
5jseA-4z0bH:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_B_1GNB611_1
(PHIAB6 TAILSPIKE)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 THR H  28
SER H  31
TYR H  32
None
0.73A 5jseB-4z0bH:
undetectable
5jseB-4z0bH:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_C_1GNC611_1
(PHIAB6 TAILSPIKE)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 THR H  28
SER H  31
TYR H  32
None
0.73A 5jseC-4z0bH:
2.7
5jseC-4z0bH:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIW_D_LOCD503_1
(TUBULIN ALPHA-1B
CHAIN
TUBULIN BETA CHAIN)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 SER H 211
ALA H 206
VAL H 205
None
0.51A 5xiwC-4z0bH:
undetectable
5xiwC-4z0bH:
21.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GBF_A_ACTA507_0
(MOLYBDOPTERIN
BIOSYNTHESIS PROTEIN
CNX1)
4z0b ANTIBODY HEAVY CHAIN
(Mus
musculus)
3 / 3 LYS H 124
SER H 121
SER H 122
None
1.02A 6gbfA-4z0bH:
undetectable
6gbfA-4z0bH:
20.48